In Brief: Quidel/Bayer
This article was originally published in The Gray Sheet
Executive Summary
Quidel/Bayer: Ink 5-year collaborative agreement under which San Diego, California-based Quidel will develop and supply automated versions of its current line of manual immunodiagnostic pregnancy, strep, H. Pylori and mononucleosis tests for use with Bayer's Clinitek line of urine chemistry analyzers. Bayer expects the first test to be available in April 1997 following FDA 510(k) clearance and anticipates development of additional tests in six-month intervals thereafter. The tests will be priced competitively with manual versions, with a "slight premium" for the added features of instrument result determination and recordability, Bayer says...